Download FREE Report Sample
Download Free sampleAflibercept, sold under the brand names Eylea and Zaltrap, is a medication used to treat wet macular degeneration and metastatic colorectal cancer.
Aflibercept Drug Market contains market size and forecasts of Aflibercept Drug in global, including the following market information:
Global Aflibercept Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Aflibercept Drug Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Aflibercept Drug companies in 2021 (%)
The global Aflibercept Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Prefilled Syring Package Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Aflibercept Drug include Regeneron, Bayer and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
surveyed the Aflibercept Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Aflibercept Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Aflibercept Drug Market Segment Percentages, by Type, 2021 (%)
Prefilled Syring Package
Vial Package
Global Aflibercept Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Aflibercept Drug Market Segment Percentages, by Application, 2021 (%)
Eye Disease
Cancer
Global Aflibercept Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Aflibercept Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Aflibercept Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Aflibercept Drug revenues share in global market, 2021 (%)
Key companies Aflibercept Drug sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Aflibercept Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Regeneron
Bayer
Sanofi
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
